Privately-held Finnish company Forendo Pharma has announced that Cristina Csimma has been appointed chairwoman of the board of directors. 16 September 2020
Israel’s largest drugmaker and generics giant Teva Pharmaceutical beat analysts’ profit forecasts for the second quarter, with a slightly smaller dip in profits at $1.8 billion. 5 August 2020
While revenues declined 2% to $5.4 billion, USA-based drugmaker Eli Lilly beat profit forecasts for the second quarter of 2020, the firm announced on Thursday. 30 July 2020
Growing revenues and profitability in step with pipeline development, British drugmaker AstraZeneca posted an upbeat second quarter results statement on Thursday, with a strong focus on efforts to combat the novel coronavirus. 30 July 2020
Despite second quarter sales being undercut by the coronavirus pandemic, French drugs and vaccines specialist Sanofi has raised its projection for the year, spurred by cost cutting measures and the sale of its stake in Regeneron Pharmaceuticals. 29 July 2020
LEO Pharma’s UK and Ireland business has appointed a new medical affairs lead, Amit Aggarwal, formerly director of UK medical affairs at Bayer. 23 July 2020
Following the appointment of Haseeb Ahmad to the role of global head of value and access and commercial development, Chinmay Bhatt has taken on the position of managing director UK, Ireland & Nordics for Novartis. 21 July 2020
US clinical-stage biopharma company Scholar Rock today announced the appointment of Tony Kingsley as president and chief executive, effective August 1, 2020. 14 July 2020
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Dr Monica Shaw and Nathalie Joannes will join the executive leadership team adding seasoned experience and international profile to the company. 1 July 2020
UK-based Indivior’s shares rose nearly 4% to 79.05 pence in early trading, after it announced that, effective today, Mark Crossley is appointed chief executive. However, the stock was down 1% at 78.00 pence by late morning. 29 June 2020
The European Medicines Agency (EMA) Management Board has announced its nomination for the new executive director of the Agency to replace the outgoing Professor Guido Rasi, who is due to end his term in the position that he has held since 2011 (minus an off-stint due to a controversy over the selection procedure). 25 June 2020
US RNA (mRNA) therapeutics and vaccines specialist Moderna today announced that Ray Jordan has joined the firm as chief corporate affairs officer, effective Monday, June 15, 2020. 16 June 2020
Mundipharma today announced that Marc Princen has joined the Mundipharma network of independently associated companies as the global chief executive, effective June 1, 2020. 15 June 2020
As part of an R&D overhaul, Copenhagen-based CNS specialist Lundbeck has announced plans to reduce its headcount by around 150, mostly in Denmark. 9 June 2020
Privately-held German firm Immatics Biotechnologies today announced that Cedrik Britten has been appointed as chief medical officer (CMO) effective June 1, 2020. 4 June 2020
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Biosimilar-focused biopharmaceutical company and contract development and manufacturing organization (CDMO) Tanvex BioPharma has named Stephen Lam its new chief executive (CEO). 5 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024